Clinical trial
Evaluating the Efficacy of Photobiomodulation Therapy in the Management of Chemotherapy-induced Peripheral Neuropathy: a Randomized Controlled Trial
NCT05763706 is registered in ClinicalTrials.gov with Jessa Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Efficacy of Photobiomodulation Therapy in the Management of Chemotherapy-induced Peripheral Neuropathy: a Randomized Controlled Trial
- Lead sponsor
- Jessa Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 27, 2023
- Completion date
- March 15, 2030
- Enrollment
- 172 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced peripheral neuropathy